Curetis News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.07.20	Curetis N.V. in liquidatie informs on publication of audited FY2019 financial results and annual report (GlobeNewswire)
01.07.20	Curetis N.V. in liquidatie informs on publication of audited FY2019 financial results and annual report (GlobeNewswire)
30.04.20	Curetis N.V. in liquidatie informs on delay of publication of audited FY2019 financial results and annual report (GlobeNewswire)
20.04.20	Curetis N.V. in liquidatie to announce liquidation distribution in advance and last trading day (GlobeNewswire)
01.04.20	Curetis and OpGen Close Business Combination (GlobeNewswire)
25.03.20	Curetis N.V. Informs on OpGen’s Fourth Quarter and Full Year 2019 Financial Results and Business Update (GlobeNewswire)
16.03.20	Curetis Begins Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe (GlobeNewswire)
10.03.20	Curetis N.V. Updates on OpGen, Inc. Special Shareholders’ Meeting Held on March 10, 2020 (GlobeNewswire)
10.03.20	Curetis N.V. Reports Results of the Extraordinary General Meeting Held on March 10, 2020 (GlobeNewswire)
20.02.20	Curetis Announces Preliminary, Unaudited 2019 Condensed Combined Key Financials and Provides Business Update (GlobeNewswire)
06.02.20	Curetis and Quaphaco Enter into Unyvero Distribution Partnership for Vietnam (GlobeNewswire)
30.01.20	Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe (GlobeNewswire)
27.01.20	Curetis to Hold Extraordinary General Meeting on March 10, 2020 (GlobeNewswire)
23.01.20	Curetis To Attend Key Conferences in the First Half of 2020 (GlobeNewswire)
14.01.20	Curetis Launches Unyvero LRT Panel for BAL Specimens in the U.S. (GlobeNewswire)
20.12.19	Curetis Receives U.S. FDA 510(k) Clearance of Unyvero LRT for BAL Specimens (GlobeNewswire)
10.12.19	Ares Genetics, a Curetis Group Company, Joins NVIDIA Inception and AWS Activate Programs (GlobeNewswire)
25.11.19	Curetis Group Company Ares Genetics Wins MERCUR Innovation Prize (GlobeNewswire)
25.11.19	Curetis Expects Near-Term U.S. FDA Decision on 510(k) Clearance of Unyvero LRT for BAL Specimens (GlobeNewswire)
25.11.19	Curetis Publishes Third Quarter and 9-Month Business and Financial Update (GlobeNewswire)
14.11.19	Curetis Provides Business Update for the First Nine Months of 2019 (GlobeNewswire)
30.10.19	Curetis To Attend Key Conferences in the Fourth Quarter of 2019 (GlobeNewswire)
28.10.19	Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test (GlobeNewswire)
18.09.19	Curetis Reports Financial Results for the First Six Months of 2019 (GlobeNewswire)
16.09.19	Curetis Group Subsidiary Ares Genetics Signs R&D and Option Agreement with Leading Global IVD Corporation (GlobeNewswire)
04.09.19	Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses (GlobeNewswire)
12.08.19	Curetis Retains H.C. Wainwright & Co. as Strategic Advisor (GlobeNewswire)
08.08.19	Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing (GlobeNewswire)
01.08.19	Curetis Elects Share Settlement for Excess Entitlement Under First Tranche of Yorkville Convertible Notes (GlobeNewswire)
30.07.19	Curetis and AKO MED Ink Distribution Agreement Covering Four Countries in CEE Region (GlobeNewswire)
25.07.19	Curetis to Present at Solebury Trout European Biotech Investor Day in NYC (GlobeNewswire)
23.07.19	Curetis Files for U.S. FDA 510(k) Clearance of Unyvero LRT for BAL Specimens (GlobeNewswire)
04.07.19	Curetis Group Company Ares Genetics is Granted Key European Patent on Genetic Resistance Testing (GlobeNewswire)
02.07.19	Curetis To Attend Key Conferences in the Third Quarter of 2019 (GlobeNewswire)
28.06.19	Curetis Reports Results of the Annual General Meeting Held on June 27, 2019 (GlobeNewswire)
04.06.19	New Data on Curetis’ Unyvero LRT Panel for Pneumonia to be Presented at ASM Microbe 2019 (GlobeNewswire)
23.05.19	Curetis Reports Positive Results from Clinical Validation Study for U.S. FDA 510(k) Submission of Unyvero LRT for BAL Samples (GlobeNewswire)
21.05.19	Curetis to Receive Additional EUR 6.5 Million Financing from EIB and Yorkville (GlobeNewswire)
17.05.19	Curetis Announces Financial Results for the First Three Months of 2019 (GlobeNewswire)
15.05.19	Curetis to Hold Annual General Shareholders’ Meeting on June 27, 2019 (GlobeNewswire)
06.05.19	Curetis (CURE-NL): Partnering drives turn-round (EQS Group)
12.04.19	Press release: Curetis’ Subsidiary Ares Genetics Introduces NGS Services for Pharma and Public Health Sector at Upcoming ECCMID 2019 (GlobeNewswire)
11.04.19	Curetis Publishes Full-Year 2018 Financial Results and Updated Guidance for 2019 (GlobeNewswire)
09.04.19	Ausblick: Curetis präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net)
05.04.19	Curetis to Publish its Full-Year 2018 Financial Results on April 11, 2019 (GlobeNewswire)
04.04.19	Curetis: Study Data Presented at ECCMID 2019 Confirm Clinical Benefits of Unyvero Platform (GlobeNewswire)
02.04.19	Curetis Introduces Unyvero AMR Atlas to Support Adoption of Rapid DNA Testing for Antibiotic Resistance (GlobeNewswire)
01.04.19	Curetis To Attend Key Conferences in the Second Quarter of 2019 (GlobeNewswire)
26.03.19	Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero (GlobeNewswire)
18.02.19	Curetis’ Subsidiary Ares Genetics and QIAGEN Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Curetis

Aktien Top/Flop

Meistgelesene Nachrichten